Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, TRI, CXP

Pilatus Comparator Solutions US Expansion


LONG ISLAND, New York, November 20, 2018 /PRNewswire/ --

PCS Inc. Long Island US Facility fully licenced and operational

As part of Pilatus Comparator Solutions' ongoing plans to strengthen its Global footprint, the company has announced that their Long Island US Facility is now fully licenced and operational.

     (Photo: https://mma.prnewswire.com/media/787641/President_Wolfe_and_Dr_Martincic.jpg )

President Julian Wolfe says, "We have now been established and trading since April 4th 2017, but it was imperative that we established a permanent facility in the US. I am proud of the dedication put in by the team to ensure that we received the go ahead from the regulatory authorities in record time."

This move will greatly strengthen Pilatus Comparator Solutions' Global position and has already enhanced access to manufacturers and suppliers in the United States transforming the service offered to clients.

This follows on from the announcement earlier in the year highlighting the opening of the PCS GmbH facility in Germany which has greatly enhanced sourcing capabilities of the group and has ensured stability of service provision post Brexit.

https://www.pilatuscs.com/news/pilatus-clinical-services-german-subsidiary-pcs-gmbh-awarded-wdl-gdp-certificate/

To find more out about Pilatus Comparator Solutions, please take a look at our website http://www.pilatuscs.com/

Contact details:
PCS Inc.
9 -20 35th Avenue
Suite 2B
Long Island City
NY 11106
USA
T: +1(718)806-1563
E: [email protected]

SOURCE PCS Inc.


These press releases may also interest you

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....



News published on and distributed by: